111.64 Cr
2.58%
BSE Healthcare TRI
INF663L01Z52
5000.0
1000.0
1000
Anandha Padmanabhan Anjeneyan, Utsav Mehta, Vivek Sharma, Puneet Pal
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| PGIM India Healthcare Fund - Regular Plan - Growth Option | 21.89 | - | - |
| Benchmark | - | - | - |
Equity
Debt
Others
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.86 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 9.14 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 6.52 |
| ASTER DM HEALTHCARE LIMITED EQ | 6.41 |
| JB Chemicals & Pharmaceuticals Limited | 6.4 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 5.56 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 5.19 |
| Krishna Institute Of Medical Sciences Limited | 4.12 |
| Rubicon Research Ltd. | 3.99 |
| Clearing Corporation of IndiLtd. | 3.19 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 91.64 |
| Chemicals | 3.09 |
| Financial Services | 1.03 |
| Consumer Services | 0.67 |
| Information Technology | 0.47 |